Related Experiment Video
Updated: Feb 22, 2026

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
4.1K
Baicalein as a potent neuroprotective agent: A review
Kandhasamy Sowndhararajan1, Ponnuvel Deepa1, Minju Kim1
1School of Natural Resources and Environmental Sciences, Kangwon National University, Chuncheon 24341, Gangwon-do, Republic of Korea.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|September 20, 2017
Summary
Baicalein, a flavonoid from Scutellaria baicalensis, shows potent neuroprotective effects against neuronal damage. This review explores its mechanisms, offering potential for treating neurodegenerative diseases.
Area of Science:
- Pharmacology
- Neuroscience
- Natural Products Chemistry
Background:
- Neurodegenerative diseases pose significant global health challenges, with neuronal cell death as a primary factor.
- Developing effective neuroprotective agents, particularly from natural sources like phytochemicals, is a growing area of research.
- Flavonoids, abundant in fruits and vegetables, are recognized for their efficacy and low side effect profiles.
Purpose of the Study:
- To review existing literature on the neuroprotective effects of baicalein.
- To elucidate the molecular mechanisms underlying baicalein's neuroprotective actions.
- To highlight baicalein's potential as a therapeutic agent for neurotoxicity-mediated diseases.
Main Methods:
- Literature review of in vitro and in vivo studies on baicalein.
- Analysis of phytochemical properties of flavonoids, specifically baicalein from Scutellaria baicalensis.
- Examination of reported molecular mechanisms of neuroprotection.
Main Results:
- Baicalein exhibits significant neuroprotective properties in various experimental systems.
- Studies indicate diverse molecular pathways through which baicalein exerts its effects.
- Baicalein's efficacy is linked to its flavonoid structure and natural origin.
Conclusions:
- Baicalein is a promising natural compound with demonstrated neuroprotective capabilities.
- Understanding baicalein's mechanisms can guide the development of novel treatments for neurodegenerative conditions.
- Further research into baicalein could lead to new therapeutic strategies targeting neurotoxicity.
More Related Videos
Related Concept Videos
The Blood-brain Barrier
53.8K
Overview
53.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.5K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K

